TD Cowen raised the firm’s price target on Emerson (EMR) to $150 from $130 and keeps a Buy rating on the shares following a transfer of coverage. The firm says strength in the company’s Process unit, a possible discrete recovery, and consistent upgrading of the margin profile through acquisitions drives its bullish view on the shares.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: